chr11-55665492-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004704.2(OR4C6):c.326G>T(p.Gly109Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004704.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR4C6 | NM_001004704.2 | c.326G>T | p.Gly109Val | missense_variant | 2/2 | ENST00000314259.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR4C6 | ENST00000314259.5 | c.326G>T | p.Gly109Val | missense_variant | 2/2 | NM_001004704.2 | P1 | ||
OR4C6 | ENST00000690330.1 | c.326G>T | p.Gly109Val | missense_variant | 1/1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151870Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250912Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135580
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461798Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727210
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151870Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74170
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.326G>T (p.G109V) alteration is located in exon 1 (coding exon 1) of the OR4C6 gene. This alteration results from a G to T substitution at nucleotide position 326, causing the glycine (G) at amino acid position 109 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at